Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

KORU Medical Systems (KRMD) Cost of Revenue (2020 - 2025)

KORU Medical Systems (KRMD) has disclosed Cost of Revenue for 11 consecutive years, with $4.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Cost of Revenue rose 38.2% to $4.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $14.7 million, a 23.77% increase, with the full-year FY2024 number at $12.3 million, up 4.28% from a year prior.
  • Cost of Revenue was $4.1 million for Q3 2025 at KORU Medical Systems, up from $3.7 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $4.1 million in Q3 2025 to a low of $2.2 million in Q1 2021.
  • A 5-year average of $3.0 million and a median of $3.0 million in 2023 define the central range for Cost of Revenue.
  • Peak YoY movement for Cost of Revenue: soared 51.07% in 2021, then dropped 22.6% in 2023.
  • KORU Medical Systems' Cost of Revenue stood at $2.7 million in 2021, then rose by 22.86% to $3.3 million in 2022, then dropped by 12.6% to $2.9 million in 2023, then increased by 14.74% to $3.3 million in 2024, then grew by 26.31% to $4.1 million in 2025.
  • Per Business Quant, the three most recent readings for KRMD's Cost of Revenue are $4.1 million (Q3 2025), $3.7 million (Q2 2025), and $3.6 million (Q1 2025).